Demo Sign up Log In

Tg Therapeutics Inc (TGTX)

R&D Expenses

$225.80M

TTM · Period ending: Jun 30, 2026 · USD

TGTX R&D Expenses

Latest reported$225.80Mperiod endingJun 30, 2026

Latest reported$225.80Mperiod endingJun 30, 2026

TGTX R&D Expenses ($1.10M → $225.80M)

Annual R&D Expenses

High-resolution chart · PNG

TGTX r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period ending	R&D Expenses (USD)
Dec 31, 2025	160,215,000
Dec 31, 2024	94,291,000
Dec 31, 2023	76,192,000
Dec 31, 2022	125,352,000
Dec 31, 2021	222,579,000
Dec 31, 2020	165,896,000
Dec 31, 2019	154,180,000
Dec 31, 2018	153,793,000
Dec 31, 2017	96,886,134
Dec 31, 2016	66,489,820
Dec 31, 2015	43,445,817
Dec 31, 2014	31,354,781
Dec 31, 2013	12,621,161
Dec 31, 2012	20,572,182
Dec 31, 2011	327,283
Dec 31, 2010	495,793
Dec 31, 2009	40,376
Dec 31, 2008	1,802,792
Dec 31, 2007	8,535,687
Dec 31, 2006	6,172,845
Dec 31, 2005	17,065,884
Dec 31, 2004	4,152,994
Dec 31, 2003	1,724,043
Dec 31, 2002	539,752
Dec 31, 2001	886,716
Dec 31, 2000	1,130,345
Dec 31, 1999	1,100,000
Dec 31, 1998	3,000,000
Dec 31, 1997	2,600,000
Dec 31, 1996	1,100,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.